Chondrocyte anabolic and catabolic pathways (N/A)

Chondrocyte anabolic and catabolic pathways represent the metabolic balance within articular cartilage responsible for maintaining the structural integrity of the extracellular matrix (ECM). Anabolic processes involve the synthesis of key structural proteins such as type II collagen and aggrecan, primarily regulated by growth factors like Transforming Growth Factor-beta (TGF-beta) and Insulin-like Growth Factor 1 (IGF-1) [1][2]. Conversely, catabolic processes involve the enzymatic breakdown of the ECM by proteases such as Matrix Metalloproteinase-13 (MMP-13) and A Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 (ADAMTS-5) [3][4]. These catabolic activities are typically triggered by pro-inflammatory cytokines, including Interleukin-1 beta (IL-1beta) and Tumor Necrosis Factor-alpha (TNF-alpha) [5]. In a healthy joint, these two opposing pathways exist in a state of dynamic equilibrium to ensure tissue longevity; however, in degenerative diseases like osteoarthritis, the balance shifts toward catabolism, leading to progressive cartilage loss [6]. Therapeutic strategies aim to restore this homeostasis by either inhibiting catabolic enzymes or stimulating anabolic repair mechanisms through various signaling modulators [7]. [1] Sophia Fox AJ, et al. (2009) Sports Health. [2] Fortier LA, et al. (2011) Clin Orthop Relat Res. [3] Goldring MB, et al. (2011) Mod Rheumatol. [4] Verma P, Dalal K. (2011) J Cell Biochem. [5] Kapoor M, et al. (2011) Nat Rev Rheumatol. [6] Mobasheri A, et al. (2017) F1000Res. [7] Latourte A, et al. (2020) Ann Rheum Dis.

Other names

Cartilage metabolismChondrocyte homeostasisExtracellular matrix turnoverArticular cartilage remodeling

Restoration of cartilage homeostasis by inhibiting catabolic proteases and pro-inflammatory cytokines or by activating anabolic growth factor signaling and matrix protein synthesis.